| 1. |
- Gustafsson Stolt, Ulrica, 1965-, et al.
(author)
-
Information and informed consent in a longitudinal screening involving children : a questionnaire survey
- 2005
-
In: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438. ; 13, s. 376-383
-
Journal article (peer-reviewed)abstract
- This empirical study explores participants' perceptions of information and understanding of their children's and their own involvement in a longitudinal screening, the ABIS Study. ABIS (All Babies In Southeast Sweden) is a multicentre, longitudinal research screening for Type 1 diabetes and multifactorial diseases involving 17 005 children and their families. For this study, a random selection of mothers was made, using perinatal questionnaire serial numbers from the ABIS study. In total, 293 of these mothers completed an anonymous questionnaire (response rate 73.3%). Our findings from the questionnaire indicate a marked difference between the reported satisfaction with and understanding of the information provided on the one hand and the significant lack of knowledge of some of the aims and methods of the ABIS screening on the other, namely concerning high-risk identification of involved children, potential prevention and future questionnaires. Two questions evoked by our results are: (1) what information is required for participants in longitudinal studies involving children? and (2) how do we ensure and sustain understanding, and thus in a prolonging, informed consent in these studies? This study underlines the importance of an increased understanding of the ethical issues that longitudinal research on children raise and the need to discuss how information and informed consent strategies should be analysed and designed in longitudinal studies.
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- van Veldhuisen, D. J., et al.
(author)
-
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
- 2009
-
In: European Journal of Heart Failure. - 1879-0844. ; 11:12, s. 1143-51
-
Journal article (peer-reviewed)abstract
- AIMS: Heart failure (HF) patients increasingly receive device therapy, either an implantable cardioverter defibrillator (ICD) or a biventricular pacemaker, also called cardiac resynchronization therapy (CRT), or a CRT device with an ICD (CRT-D). However, epidemiological data on the use of device therapy in Europe are limited. METHODS AND RESULTS: Data on implantation rates for conventional pacemakers, ICD, CRT, and CRT-D in 15 Western European countries were obtained from the Eucomed Registry for the 5-year period 2004-2008. Implantation of conventional pacemakers increased by 9% in Europe over the 5 years (reaching 907/million in 2008) and there were significant differences between countries. Implantable cardioverter defibrillator implantations increased by 75% from 80/million in 2004 to 140/million in 2008, and differences between countries were larger than those for conventional pacemakers. Implantation rates for CRT-P alone increased slightly from 2004 to 2006, but remained at 25/million thereafter in Europe overall. The total number of CRT implants (CRT-P and -D) markedly increased from 46/million in 2004 to 99/million in 2008 (115%), but this was mainly due to more CRT-D implants, i.e. an increase in the proportion of CRT-D (from 55% in 2004 to 75% in 2008). Implantation rates for ICD, CRT, and CRT-D remained markedly different throughout the study period between countries. CONCLUSION: Implantation rates of devices for HF, in particular ICD and CRT-D, have increased significantly between 2004 and 2008 in Europe, but there remain major differences between countries.
|
|
| 5. |
- Zhou, Qi, et al.
(author)
-
Copolymer, modified polymer carbohydrate material, modified buld polymer, composite material, and methods of preparation
- 2006
-
Patent (pop. science, debate, etc.)abstract
- The present invention relates to a novel group of copolymers comprising a soluble carbohydrate polymer (SCP), which typically is a non-starch carbohydrate, and a macromolecule covalently attached to the SCP. The macromolecule may e.g. be a hydrophobic copolymer, a polyelectrolyte polymer or a biodegradable polymer. The present invention furthermore relates to a method of preparing the copolymer, products comprising the copolymer, and to methods of preparing the products comprising the copolymer. The products comprising a copolymer are for example a polymeric carbohydrate material (PCM) modified by attachment of a copolymer, and a composite material comprising the modified PCM.
|
|
